Back
CureVac NV 10K Form
Sell
44
CVAC
CureVac NV
Last Price:
$5.45
Seasonality Move:
-17.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CVAC News And Ratings
See the #1 stock for the next 7 days that we like better than CVAC
CVAC Financial Statistics
Sales & Book Value
| Annual Sales: | $579.3M |
|---|---|
| Cash Flow: | $-44.1M |
| Price / Cash Flow: | 7.88 |
| Annual Sales: | $3.11 |
| Price / Book: | 1.77 |
Profitability
| EPS (TTM): | 0.90320 |
|---|---|
| Net Income (TTM): | $203.9M |
| Gross Margin: | $464.7M |
| Return on Equity: | 32.68% |
| Return on Assets: | 25.91% |
CureVac NV Earnings Forecast
Key CureVac NV Financial Ratios
-
The Gross Profit Margin over the past 7 years for CVAC is 80.23%.
-
The Selling, General & Administrative Expenses for CVAC have been equal to 11.36% of Gross Profit Margin.
-
The Research & Development expenses have been 28.59% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of CVAC is 30.30% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 3 years.
CureVac NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CVAC |
| Website: | curevac.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.65 |
| Quick Ratio: | 7.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 7.04 |
|---|---|
| Forward P/E Ratio: | 0 |
CVAC Technical Analysis vs Fundamental Analysis
Sell
44
CureVac NV (CVAC)
is a Sell
Is CureVac NV a Buy or a Sell?
-
CureVac NV stock is rated a SellThe current CureVac NV [CVAC] share price is $5.49. The Score for CVAC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.